Literature DB >> 3439804

In vitro antimicrobial activity against reference strains and field isolates of Treponema hyodysenteriae.

K Kitai1, M Kashiwazaki, Y Adachi, K Kunugita, A Arakawa.   

Abstract

The in vitro susceptibilities of eight isolates of Treponema hyodysenteriae from pigs naturally infected with swine dysentery between 1976 and 1983 were determined by an agar dilution technique. Carbadox, olaquindox, tiamulin, metronidazole, furazolidone, and monensin were the most active against these field isolates regardless of the year of recovery. The influence of inoculum size on the MICs against four reference strains of T. hyodysenteriae was studied. Various degrees of activities of ampicillin and lincomycin were found, depending on the inoculum size. The effect of successive in vitro subcultures on the susceptibility of a reference strain of T. hyodysenteriae was examined. The strain resistant to tylosin became susceptible to the drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439804      PMCID: PMC175831          DOI: 10.1128/AAC.31.12.1935

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Activity of various compounds against a pathogenic strain of Treponema hyodysenteriae.

Authors:  G Laber
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-10

2.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  Growth in Treponema hyodysenteriae in liquid medium.

Authors:  J M Kinyon; D L Harris
Journal:  Vet Rec       Date:  1974-09-07       Impact factor: 2.695

4.  Inoculation of pigs with Treponema hyodysenteriae (new species) and reproduction f the disease.

Authors:  D L Harris; R D Glock; C R Christensen; J M Kinyon
Journal:  Vet Med Small Anim Clin       Date:  1972-01

5.  The production of dysentery in swine by feeding cultures containing a spirochaete.

Authors:  D J Taylor; T J Alexander
Journal:  Br Vet J       Date:  1971-11

6.  In vitro susceptibility of Treponema hyodysenteriae to carbadox, virginiamycin, and tylosin.

Authors:  B J Williams; W E Babcock
Journal:  Vet Med Small Anim Clin       Date:  1976-07

7.  Epizootiological studies on R plasmid with carbadox resistance.

Authors:  K Ohmae; S Yonezawa; N Terakado
Journal:  Nihon Juigaku Zasshi       Date:  1983-04

8.  Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

9.  Selective medium for isolation of Treponema hyodysenteriae.

Authors:  J G Songer; J M Kinyon; D L Harris
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

10.  Isolation of Treponema hyodysenteriae from feces of pigs affected with swine dysentery by use of a medicated medium.

Authors:  M Kashiwazaki; T Takohata; T Kume
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1977
View more
  3 in total

1.  Novel method for measuring growth of Treponema hyodysenteriae and its application for monitoring susceptibility of clinical isolates to antimicrobial agents.

Authors:  F H Weber; D L Earley
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

2.  Antimicrobial susceptibility testing of porcine Brachyspira (Serpulina) species isolates.

Authors:  M Karlsson; C Fellström; A Gunnarsson; A Landén; A Franklin
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

3.  Drug-susceptibility of isolates of Brachyspira hyodysenteriae isolated from colonic mucosal specimens of pigs collected from slaughter houses in Japan in 2009.

Authors:  Keita Kajiwara; Midori Kozawa; Takuya Kanazawa; Kouji Uetsuka; Hiromi Nakajima; Yoshikazu Adachi
Journal:  J Vet Med Sci       Date:  2015-11-22       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.